INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY (Republic of Korea)
DAESANG CORPORATION (Republic of Korea)
Inventor
Kim, Dong Yeop
Kuthirakkal, Rajitha
Ryu, Byung Hee
Bae, Jin Woo
Koo, Hyun
Kim, Yu-Jin
Abstract
Weissella confusaWeissella cibariaLactobacillus sakeiLeuconostoc mesenteroidesStreptococcus mutansCandida albicansCandida albicans, and the like, and thus can be effectively used as an anti-biofilm composition and a composition for preventing or treating oral diseases.
Flavonifractor plautiiFlavonifractor plautiiFlavonifractor plautii or a D-allulose epimerase variant W29K/A77S/G216S/M234I. Therefore, the novel allulose epimerase variant according to the present invention can shorten production time and reduce production costs in an enzyme conversion reaction at an industrial scale for mass production of allulose.
The present invention relates to: a starch-based biodegradable resin composition having improved odor, water leaching, and mechanical strength as a result of simultaneously using an essential oil masking agent and a compatibilizer that reacts with a hydroxy group of starch; and a biodegradable film using same.
The present invention relates to a method for producing 1,4-butanediol using a 1,4-butanediol-producing microorganism. The method for producing 1,4-butanediol can efficiently produce 1,4-butanediol by culturing a microorganism that produces 1,4-butanediol from glutamic acid under optimal medium conditions.
C12P 7/18 - Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/52 - Genes encoding for enzymes or proenzymes
The present invention relates to: a starch-based biodegradable resin composition having improved color, odor, and mechanical strength as a result of using an essential oil masking agent and a natural crosslinking agent that reacts with a hydroxy group of starch; and a biodegradable film using same.
The present invention relates to a novel zinc-binding dehydrogenase variant and a method of producing an L-aromatic amino acid using the same. The zinc-binding dehydrogenase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting zinc-binding dehydrogenase to change the enzymatic activity of the zinc-binding dehydrogenase, and a recombinant microorganism comprising the variant is capable of efficiently producing an L-aromatic amino acid.
The present invention relates to a food tray by which food such as fried dumplings can be cooked using a cooking appliance such as an air fryer, a microwave oven, or a conventional oven. The food tray according to the present invention includes at least one food accommodation unit. The food accommodation unit includes: a food accommodation space that includes a first side part and a second side part facing each other, a front surface part and a rear surface part respectively connecting the ends of the first side part and the second side part, and a bottom part forming the bottom surface; a central support part including a first central support part and a second central support part that are connected to the first side part and the second side part, respectively, and protrude upward from the bottom part; a front surface support part and a rear surface support part formed, along the longitudinal direction of the food accommodation unit, on the front surface side and the rear surface side, respectively, of the central support part; and a trench part formed on the bottom surface of the food accommodation space.
B65D 81/34 - Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging foodstuffs intended to be cooked or heated within the package
B65D 1/36 - Trays or like shallow containers with moulded compartments or partitions
The present invention relates to: a mutant microorganism with enhanced L-glutamic acid production capability; and a method for producing L-glutamic acid using same. The mutant microorganism has enhanced activities of a sugar permease and a sugar kinase, and thus may have an improved production yield of L-glutamic acid compared to a parent strain.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention provides allulose crystal particles exhibiting a particle size distribution in which 80-95 wt% of the total crystal particles have a size of 300 μm or greater and 0.1-5 wt% have a size of less than 212 μm, and having an average aspect ratio (the ratio of major axis length to minor axis length) of 1 to 3 and an average particle size of 400-520 μm. The allulose crystal particles according to the present invention exhibit low hygroscopicity and high anti-caking properties. Accordingly, the allulose crystal particles of the present invention can be stored and distributed for extended periods without degradation in quality.
The present invention provides a method for preparing allulose crystals, comprising the steps of: (a) adding allulose seed crystals to an allulose-containing mother liquor and performing a primary crystallization reaction while a reduced pressure condition of 10-100 mb is maintained and under a temperature gradient condition in which the temperature of the allulose-containing mother liquor is gradually lowered; and (b) releasing the reduced pressure condition when the allulose crystal precipitation rate of the primary crystallization reaction has reached 12% or more, and performing a secondary crystallization reaction while the supersaturated state of the metastable zone is maintained and under a temperature gradient condition in which the temperature of a D-allulose-containing mother liquor is gradually lowered. Allulose crystal particles obtained using the method for preparing allulose crystals, of the present invention, have a large average particle size, are inhibited from caking even if stored for a long time and have low hygroscopicity and excellent flowability. In addition, when the method for preparing allulose crystals, of the present invention, is used, allulose crystallization yield can be improved.
The present invention relates to: a polynucleotide for a novel promoter capable of regulating the expression of a target gene in a microorganism of the genus Corynebacterium; a recombinant vector comprising the polynucleotide; a transformant transformed with the recombinant vector; and a method for producing L-amino acid using the transformant. A polynucleotide having promoter activity according to the present invention can enhance or weaken the expression of a target gene, and can efficiently regulate the production of a target substance through a transformant into which the polynucleotide is introduced, and thus can be effectively used to produce L-amino acids.
C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
Provided is a mutant strain having improved aromatic amino acid production capability as a result of inactivation or weakening of activity of glutaminase which is expressed by glutaminase B (glsB) gene.
The present invention relates to a novel variant of pyruvate kinase 2 and a method of producing L-aromatic amino acids using the same. The pyruvate kinase 2 variant is obtained by substituting one or more amino acids in the amino acid sequence constituting pyruvate kinase 2 to change the activity of the protein, and a recombinant microorganism comprising the variant is capable of efficiently producing L-tryptophan, L-phenylalanine, or L-tyrosine.
The present invention relates to a novel variant of DNA-binding transcriptional regulator MalT and a method of producing L-aromatic amino acids using the same. The DNA-binding transcriptional regulator MalT variant is obtained by substituting one or more amino acids in the amino acid sequence constituting DNA-binding transcriptional regulator MalT to change the activity of the protein, and a recombinant microorganism comprising the variant is capable of efficiently producing L-tryptophan, L-phenylalanine, or L-tyrosine.
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Chemicals for use in animal nutritional food industry;
fertilisers; microorganisms, other than for medical
purposes; chemical additives for use in the manufacture of
food and beverages; chemical agents for use in the
manufacture of dietary supplements; chemical additives for
food industry; microalgae for the food industry; amino acid
for food industry; artificial sweeteners for the food
industry; flavor enhancing preparations for food industry;
enzymes for the food industry; chemical additives for use in
the manufacture of cosmetics. Air fragrancing preparations; pre-moistened cleansing
tissues; cleaning preparations; fabric softeners for laundry
use; hand cleansers; room fragrancing preparations;
cosmetics for animals; soaps for personal use; toothpaste;
cosmetics. Glutamine preparations; nutritional supplements for animal
foodstuffs; lysine preparations; mineral food supplements;
vitamin preparations; sanitary pads; nutraceuticals for use
as a dietary supplement; dietary fiber; starch for dietetic
or pharmaceutical purposes; arginine preparations; dietary
supplements consisting of amino acids; milk sugar for
pharmaceutical purposes; nutritional supplements; babies'
diapers; dietary supplements for infants; preparations of
microorganisms for medical and veterinary use; cotton for
medical purposes; dietetic substances adapted for medical
use; amino acid preparations for medical purposes; drugs for
medical purposes. Cereal-based processed products; confectionery; malt for
human consumption; edible salt; food flavorings, other than
essential oils; gluten additives for culinary purposes;
seasonings; tea; tea-based beverages; coffee; spices;
leaven; food flavoring, being essential oils; food
flavorings [essential oils]; flavorings for beverages
[essential oils].
20.
MUTANT MICROORGANISM EXHIBITING ENHANCED 1,4-BUTANEDIOL PRODUCTION CAPABILITY, AND METHOD FOR PRODUCING 1,4-BUTANEDIOL BY USING SAME
The present invention relates to a mutant microorganism exhibiting enhanced 1,4-butanediol production capability and a method for producing 1,4-butanediol by using same, wherein attenuation of serine/threonine protein kinase activity in the mutant microorganism enhances the flux of the 1,4-butanediol biosynthetic pathway, thereby enabling efficient production of 1,4-butanediol.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a mutant microorganism having enhanced 1,4-butanediol production capability and a method for producing 1,4-butanediol using same. The mutant microorganism attenuates the activities of formaldehyde dehydrogenase, alcohol dehydrogenase A, and acetaldehyde dehydrogenase, which are expected to be involved in a degradation pathway for 1,4-butanediol, thereby inhibiting degradation of 1,4-butanediol and improving the production yield of 1,4-butanediol.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a novel carboxylic acid reductase variant and a method for producing 1,4-butanediol using same, wherein the carboxylic acid reductase variant has altered protein activity resulting from substitution of one or more amino acids in the amino acid sequence constituting carboxylic acid reductase, so that a transformant or recombinant microorganism comprising same can efficiently produce the carboxylic acid reductase.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 7/18 - Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Caldibacillus debilisCaldibacillus debilis strain, and exhibits a very high conversion activity of glucose to fructose and excellent thermal stability. Therefore, when the method for preparing fructose, according to one embodiment of the present invention, is used, fructose can be prepared in a high yield from glucose. The xylose isomerase used in the method for preparing fructose, according to one embodiment of the present invention, has excellent thermal stability, and thus enables fructose to be continuously prepared for a long period of time.
The present invention relates to a novel amino acid derivative and a method for preparing same. In the method for preparing an amino acid derivative, various substituents can be introduced through a simple chemical reaction.
C07C 237/16 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
C07C 231/12 - Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
C07C 237/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
27.
AMINO ACID DERIVATIVE AND METHOD FOR PREPARING SAME
The present invention relates to a novel amino acid derivative and a method for preparing same and, to a method for preparing an amino acid derivative, being capable of introducing various substituents through a simple chemical reaction.
C07C 237/16 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
C07C 231/12 - Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
C07C 237/06 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
(1) Chemicals for use in animal nutritional food industry; fertilisers; microorganisms, other than for medical purposes; chemical additives for use in the manufacture of food and beverages; chemical agents for use in the manufacture of dietary supplements; chemical additives for food industry; microalgae for the food industry; amino acid for food industry; artificial sweeteners for the food industry; flavor enhancing preparations for food industry; enzymes for the food industry; chemical additives for use in the manufacture of cosmetics.
(2) Air fragrancing preparations; pre-moistened cleansing tissues; cleaning preparations; fabric softeners for laundry use; hand cleansers; room fragrancing preparations; cosmetics for animals; soaps for personal use; toothpaste; cosmetics.
(3) Glutamine preparations; nutritional supplements for animal foodstuffs; lysine preparations; mineral food supplements; vitamin preparations; sanitary pads; nutraceuticals for use as a dietary supplement; dietary fiber; starch for dietetic or pharmaceutical purposes; arginine preparations; dietary supplements consisting of amino acids; milk sugar for pharmaceutical purposes; nutritional supplements; babies' diapers; dietary supplements for infants; preparations of microorganisms for medical and veterinary use; cotton for medical purposes; dietetic substances adapted for medical use; amino acid preparations for medical purposes; drugs for medical purposes.
(4) Cereal-based processed products; confectionery; malt for human consumption; edible salt; food flavorings, other than essential oils; gluten additives for culinary purposes; seasonings; tea; tea-based beverages; coffee; spices; leaven; food flavoring, being essential oils; food flavorings [essential oils]; flavorings for beverages [essential oils].
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Glutamine preparations; nutritional supplements for animal foodstuffs; lysine preparations; mineral food supplements; vitamin preparations; sanitary pads; nutraceuticals for use as a dietary supplement; dietary fiber; starch for dietetic or pharmaceutical purposes; arginine preparations; dietary supplements consisting of amino acids; milk sugar for pharmaceutical purposes; nutritional supplements; babies' diapers; dietary supplements for infants; preparations of microorganisms for medical and veterinary use; cotton for medical purposes; dietetic substances adapted for medical use; amino acid preparations for medical purposes; drugs for medical purposes
30.
MICROORGANISM OF CORYNEBACTERIUM GENUS HAVING ENHANCED L-ARGININE OR L-CITRULLINE PRODUCTIVITY AND A METHOD FOR PRODUCING L-ARGININE OR L-CITRULLINE USING THE SAME
The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylglutamate kinase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline in an increased yield compared to a parent strain.
The present invention relates to a gene variant of the transcriptional regulator LysG and a method for producing L-citrulline or L-arginine using same. The gene variant of the transcriptional regulator LysG according to the present invention has protein activity that is altered due to the mutation of one or more bases in the base sequence of a gene encoding the transcriptional regulator LysG, and thus, it is possible to effectively produce L-citrulline or L-arginine from a recombinant microorganism comprising the variant.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a Corynebacterium sp. mutant microorganism producing L-glutamic acid and a method of producing L-glutamic acid using the same, and more specifically, to a novel oxidoreductase variant involved in the L-glutamic acid biosynthetic pathway, a polynucleotide, and a transformant, as well as a method of producing L-glutamic acid using the same. The oxidoreductase variant according to the present invention is obtained by substituting one or more amino acids in the amino acid sequence constituting oxidoreductase to change the enzymatic activity of the oxidoreductase, and a recombinant microorganism comprising the oxidoreductase variant is capable of efficiently producing L-glutamic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a Corynebacterium sp. mutant microorganism producing L-glutamic acid and a method of producing L-glutamic acid using the same, and more specifically, to a novel NADP-dependent malic enzyme variant involved in the L-glutamic acid biosynthetic pathway, a polynucleotide, and a transformant, as well as a method of producing L-glutamic acid using the same. The NADP-dependent malic enzyme variant according to the present invention is obtained by substituting one or more amino acids in the amino acid sequence constituting NADP-dependent malic enzyme to change the enzymatic activity of the NADP-dependent malic enzyme, and a recombinant microorganism comprising the NADP-dependent malic enzyme variant is capable of efficiently producing L-glutamic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to an Escherichia microorganism with improved L-isoleucine productivity and a method for producing L-isoleucine using same, the Escherichia microorganism having reduced or deactivated acetohydroxy acid synthases I and III activity but stronger acetohydroxy acid synthase II activity to thus strengthen L-isoleucine biosynthesis pathways and reduce production of by-products, thereby allowing the L-isoleucine production level to be greater than that with the parent strain.
MICROORGANISMS OF BREVIBACTERIUM SPP. OR CORYNEBACTERIUM SPP. HAVING IMPROVED L-ISOLEUCINE PRODUCTIVITY AND METHOD FOR PRODUCING L-ISOLEUCINE USING SAME
The present invention relates to microorganisms of the Brevibacterium spp. or Corynebacterium spp. having improved L-isoleucine productivity and a method for producing L-isoleucine using same, the activities of endogenous acetolactate synthase being reduced or deactivated while the activity of exogenous acetolactate synthase II is strengthened to allow the L-isoleucine production level, with reduced by-product production, to be greater than that with the mother strain.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
MICROORGANISM OF GENUS CORYNEBACTERIUM WITH IMPROVED L-CITRULLINE OR L-ARGININE PRODUCTIVITY AND METHOD FOR PRODUCING L-CITRULLINE OR L-ARGININE USING SAME
The present invention relates to a microorganism of the genus Corynebacterium with improved L-citrulline or L-arginine productivity and a method for producing L-citrulline or L-arginine using same. The microorganism of the genus Corynebacterium can improve the production yield of L-citrulline or L-arginine compared to pre-mutation, due to strengthened activity of glutamine synthase, aspartate aminotransferase and carbamoyl phosphate synthase.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
The present invention relates to an Escherichia microorganism with improved L-isoleucine productivity and a method for producing L-isoleucine using same, the Escherichia microorganism having reduced or deactivated threonine operon leader peptide and threonine dehydrogenase activity to thus strengthen L-isoleucine biosynthesis pathways and reduce production of by-products, thereby allowing the L-isoleucine production level to be greater than that with the parent strain.
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
32 - Beers; non-alcoholic beverages
Goods & Services
Processed sweet potatoes; kelp, processed; processed eggs;
processed brown seaweed; short rib soup (galbi tang); food
products consisting principally of fruit; toasted laver;
laver-based snack foods; kimchi; kimchi jjigae [Korean dish
consisting primarily of fermented vegetables, pork and
tofu]; frozen beans; minced garlic, preserved; doenjang
jjigae [Korean dish consisting primarily of tofu with
soybean paste]; processed beans, namely, bean-based foods
excluding bean curds and foodstuffs made from bean curds;
tofu; foods prepared from bean curds (tofu); grilled short
rib patties; anchovy, salted, fermented and preserved in
liquid; prepared side dishes consisting primarily of meat,
fish, poultry or vegetable; food products consisting
principally of fermented vegetable; silkworm chrysalis for
human consumption; bacon; bottled vegetables; preserved,
frozen, dried and cooked fruits and vegetables; fish and
shellfish, not live, for food; samgyetang [Korean ginseng
chicken soup]; sausages; soups; jellies for food; sesame oil
for food; edible eggs; edible oils and fats; meat; fish
cakes; food products made from fish and shellfish; yogurt;
vegetable juices for cooking; processed dairy products; milk
products; processed meat products; jerky; seasoned laver
(jaban-gim); jams; tuna, not live; food products consisting
principally of vegetable; vegetable salads; cheese; chicken
balls; croquettes; processed edible seaweed products; ham. Soya sauce; fermented hot pepper paste (gochujang); hot
pepper powder [spice]; cereal-based processed products;
flour and preparations made from cereals; fructose for food;
confectionery; noodles; Korean buckwheat noodles
(naeng-myun); nurungji [scorched rice crust]; instant rice;
polished cereals; soybean paste being seasoning; rice cakes;
cooked dish consisting primarily of stir-fried rice cake
with fermented hot pepper paste (topokki); instant noodles;
mayonnaise; Korean-style dumplings (mandu); wheat flour;
stir-fried rice; bread; salad dressings; sugar; somen
noodles; sauces; cooked dish consisting primarily of dough
flakes with broth (sujebi); spaghetti; cereal bars; flour
for food; malt for human consumption; starch syrup for food;
edible salt; starch for food; vinegar; ice cream; Chinese
noodles; meat tenderizers for culinary purposes;
oligosaccharides for culinary purposes; udon noodles;
seasonings; tea; tea-based beverages; natural sweeteners;
fermented soybean paste being seasoning; curry [spice];
coffee; ketchup [sauce]; pasta; pizzas; hot dogs
(sandwiches); spices; small walnut-flavored cake in the size
and shape of a walnut; pepper powder [spice]; Korean
condiment made from salted and fermented seafood (jeotgal). Fruit juices; mineral water; lemonades; beer; extracts of
hops for making beer; powders for effervescing beverages;
non-alcoholic fruit extracts; non-alcoholic beverages;
waters [beverages]; soda drinks; smoothies; non-alcoholic
beverages, namely, beverages made from vinegar;
non-alcoholic rice punch (sikhye); powders for making
fruit-based beverages; vegetable-based beverages and
fruit-based beverages; non-alcoholic vegetable juice
beverages; soft drinks, non-carbonated; aerated water; red
ginseng drinks.
The present invention relates to a microorganism of the genus Corynebacterium with an improved ability to produce L-lysine and a method for producing L-lysine, using same. The microorganism of the genus Corynebacterium exhibits enhanced activities of a glucose-facilitated diffusion transporter and glucokinase, and thus can have improved L-lysine production yield as compared to a parent strain or cases where a glucose-facilitated diffusion transporter or glucokinase is enhanced alone.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a novel phosphoenolpyruvate carboxylase variant and a method of producing 5′-inosinic acid using the same. The phosphoenolpyruvate carboxylase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting phosphoenolpyruvate carboxylase to change the activity of the protein, and a recombinant microorganism comprising the phosphoenolpyruvate carboxylase variant is capable of efficiently producing 5′-inosinic acid.
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
The present invention relates to a novel PTS transporter subunit EIIC variant and a method of producing 5′-inosinic acid using the same. The PTS transporter subunit EIIC variant is obtained by substituting one or more amino acids in the amino acid sequence constituting PTS transporter subunit EIIC to change the activity of the protein, and a recombinant microorganism comprising the PTS transporter subunit EIIC variant is capable of efficiently producing 5′-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
46.
Corynebacterium producing L-glutamic acid and method for producing L-glutamic acid using same
Corynebacterium sp. mutant microorganism producing L-glutamic acid and a method of producing L-glutamic acid using the same, and more specifically, to a novel biotin-protein ligase variant involved in the L-glutamic acid biosynthetic pathway, a polynucleotide, and a transformant, as well as a method of producing L-glutamic acid using the same. The biotin-protein ligase variant according to the present invention is obtained by substituting one or more amino acids in the amino acid sequence constituting biotin-protein ligase to change the enzymatic activity of the biotin-protein ligase, and a recombinant microorganism comprising the biotin-protein ligase variant is capable of efficiently producing L-glutamic acid.
C12P 13/18 - Glutamic acidGlutamine using biotin or its derivatives
C12N 9/00 - Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
47.
Corynebacterium producing l-glutamic acid and method for producing l-glutamic acid using same
Corynebacterium sp. mutant microorganism producing L-glutamic acid and a method of producing L-glutamic acid using the same, and more specifically, to a novel nicotinamide mononucleotide transporter variant involved in the L-glutamic acid biosynthetic pathway, a polynucleotide, and a transformant, as well as a method of producing L-glutamic acid using the same. The nicotinamide mononucleotide transporter variant according to the present invention is obtained by substituting one or more amino acids in the amino acid sequence constituting nicotinamide mononucleotide transporter to change the enzymatic activity of the nicotinamide mononucleotide transporter, and a recombinant microorganism comprising the nicotinamide mononucleotide transporter variant is capable of efficiently producing L-glutamic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
48.
5-dehydro-2-deoxygluconokinase variant and method for producing 5′-inosinic acid using same
The present invention relates to a novel 5-dehydro-2-deoxygluconokinase variant and a method of producing 5′-inosinic acid using the same. The 5-dehydro-2-deoxygluconokinase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting 5-dehydro-2-deoxygluconokinase to change the activity of the protein, and a recombinant microorganism comprising the 5-dehydro-2-deoxygluconokinase variant is capable of efficiently producing 5′-inosinic acid.
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
49.
MUTANT MICROORGANISM HAVING IMPROVED L-CITRULLINE OR L-ARGININE PRODUCTIVITY, AND METHOD FOR PRODUCING L-CITRULLINE OR L-ARGININE USING SAME
The present invention relates to: a mutant microorganism having improved L-citrulline or L-arginine productivity; and a method for producing L-citrulline or L-arginine using same. The mutant microorganism can improve the production yield of L-citrulline or L-arginine compared to the parent strain by weakening or inactivating the activity of a protein encoded by the NCgl2653 gene.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a method for preparing a seasoning material using a process of mixing two or more species of microbes that produce products different from each other and fermenting the microbes at the same time. In the method for preparing a seasoning material, heterogeneous microbes that produce different products, that is, different amino acids, nucleic acids, and/or organic acids, are mixed and fermented, thereby enabling the preparation of the seasoning material that increases the taste and flavor of foods through a fermented solution containing the amino acids, nucleic acids, and/or organic acids and which improves overall sensory properties of foods. Such a seasoning material can find applications in the various food fields.
The present invention relates to a mutant microorganism with an enhanced ability to produce nicotinamide mononucleotide and a method for producing nicotinamide mononucleotide, using same. The mutant microorganism can produce nicotinamide mononucleotide with a high yield by enhancing, weakening or inhibiting the expression of enzymes, such as nicotinate phosphoribosyltransferase, involved in nicotinamide mononucleotide production pathways.
One example of the present invention provides a promoter which comprises a base sequence of SEQ ID NO: 6 or a base sequence of SEQ ID NO: 27 and which regulates the expression of allulose epimerase in Corynebacterium sp. strain. The novel promoter according to the present invention can constitutively express, at a high level, a target protein, particularly an enzyme, in a Corynebacterium sp. strain. For example, by using a recombinant Corynebacterium sp. strain. that has been transformed using an expression vector comprising the novel promoter according to the present invention, allulose epimerase can be economically mass-produced or allulose can be economically mass-produced from fructose.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a starch-based biodegradable composition having excellent mechanical properties and durability and to a biodegradable film prepared using same, the starch-based biodegradable composition comprising a thermoplastic starch, a biodegradable resin, a first compatibilizer, a second compatibilizer, and a lubricant, wherein the first compatibilizer is an epoxy compound, and the second compatibilizer is a tricarboxylic acid.
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (Republic of Korea)
Inventor
Lee, Seul Gi
Yang, Da Hae
Kim, Se Wook
Hur, Sung Hwa
Hong, Sung Jun
Ham, Choong Hyun
Soung, Hyo Lin
Kim, Ho Yong
Jung, Chan Duck
Choi, June Ho
Abstract
The present invention relates to a method for producing fibrous biomass, including a hydration grinding process and a physical treatment process, the method comprising the steps of: pretreating and grinding herbaceous biomass and supplying same to a hydration extruder; supplying, to a disk refiner, the resulting hydrated biomass extrudate that has undergone hydration grinding by the hydration extruder; and physically treating the hydrated biomass extrudate by controlling the solid-to-liquid ratio of the disk refiner. The fibrous biomass produced by the method is suitable for use as a high-strength reinforcing material in a biodegradable resin composition.
Mycobacteroides abscessusMassilienseMycobacterium canariasenseMycobacterium conceptionenseMycobacterium conceptionense, and can efficiently produce 1,4-butanediol by expressing carboxylic acid reductase having high substrate activity for 4-hydroxybutyric acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
One embodiment of the present invention provides a method for purifying an allulose-containing solution, the method comprising a step of obtaining an ion-purified allulose-containing solution by passing an allulose-containing solution through an ion exchange resin column filled with a mixed-phase ion exchange resin. In the method for purifying an allulose-containing solution according to an embodiment of the present invention, the mixed-phase ion exchange resin is a mixture of a strongly acidic cation exchange resin and a weakly basic anion exchange resin, the weakly basic anion exchange resin constituting the mixed-phase ion exchange resin having an exchange capacity fraction of quaternary ammonium of 0-10%. Using the method for purifying an allulose-containing solution according to the present invention not only enables the electrical conductivity of the allulose-containing solution to be lowered to an acceptable level, but also minimizes the loss of allulose because the conversion of allulose into fructose or other materials due to a functional group of the ion exchange resin can be suppressed. Therefore, the purification method for purifying an allulose-containing solution according to an embodiment of the present invention is suitable for the mass production of high-quality allulose.
B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
The present invention relates to: a thermoplastic starch composition which has improved melt flow characteristics and processability and comprises a modified starch having a controlled molecular weight due to treatment with an acid; and a biodegradable resin composition and a film which have excellent mechanical properties and comprise the thermoplastic starch composition.
The present invention relates to a method for preparing a biodegradable resin composition using an isocyanate compound as a compatibilizing agent, and a biodegradable resin composition and a biodegradable film having, due to the method, a decreased rate of dissolution in water and thus improved durability and mechanical properties.
Corynebacterium glutamicumMycobacterium tuberculosisMycobacterium tuberculosis, and can efficiently produce 1,4-butanediol by expressing phosphopantetheinyl transferase having excellent reactivity with carboxylic acid reductase.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
Mycobacteroides abscessusMassilienseMycobacterium canariasenseMycobacterium conceptionenseMycobacterium conceptionense, and can efficiently produce 1,4-butanediol by expressing phosphopantetheinyl transferase having excellent reactivity with carboxylic acid reductase.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
Escherichia coliEscherichia coli, thereby enhancing the supply of pyridoxal 5'-phosphate used as a coenzyme in the 1,4-butanediol production pathway and efficiently producing 1,4-butanediol.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
An exemplary embodiment of the present disclosure provides an allulose epimerase expression cassette including a polynucleotide encoding allulose epimerase and a promoter which is operably linked thereto and regulates the expression of the allulose epimerase in a Corynebacterium genus strain. The promoter consists of a base sequence represented by SEQ ID NO: 1, a base sequence represented by SEQ ID NO: 9, a base sequence represented by SEQ ID NO: 10, or a base sequence represented by SEQ ID NO: 11. The allulose epimerase expression cassette may be hardly operated under a normal environment of culturing a recombinant Corynebacterium genus strain and does not induce growth inhibition of the recombinant Corynebacterium genus strain. The recombinant Corynebacterium genus strain transformed with the allulose epimerase expression cassette may grow and proliferate normally until a logarithmic phase and stably and highly express allulose epimerase after the logarithmic phase.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
One embodiment of the present disclosure provides a promoter consisting of a base sequence represented by SEQ ID NO: 6 or a base sequence represented by SEQ ID NO: 27 and regulating the expression of allulose epimerase in a Corynebacterium sp. strain. According to the present disclosure, the novel promoter may constitutively and highly express a target protein, particularly an enzyme, in a Corynebacterium sp. strain. For example, by using a recombinant Corynebacterium sp. strain transformed with an expression vector including the novel promoter according to the present disclosure, it is possible to economically mass-produce allulose epimerase or economically mass-produce allulose from fructose.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a Corynebacterium sp. microorganism having improved L-amino acid productivity and a method for producing L-amino acids using same. The Corynebacterium sp. microorganism can have an improved production yield of L-amino acids, compared to a parent strain, due to weakened activity or inactivity of a carotenoid biosynthesis enzyme.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a mutant microorganism with enhanced L-glutamic acid production capability and a method for producing L-glutamic acid using same. The mutant microorganism can exhibit improved production yield of L-glutamic acid compared to the parent strain due to the weakened or inactivated activity of the RamB protein.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
Provided in one embodiment of the present invention is a method for improving the storage stability of a saccharide-containing solution, comprising a step of irradiating a saccharide-containing solution with light-emitting diode (LED) light. Even if a saccharide-containing solution, particularly, an allulose-containing solution, is stored at various temperatures, the method according to one embodiment of the present invention delays browning of the saccharide-containing solution without affecting changes in the pH and saccharide amount of the saccharide-containing solution. In addition, if a browned saccharide-containing solution is stored using the method according to one embodiment of the present invention, the browned saccharide-containing solution can be decolorized.
A23B 2/00 - Preservation of foods or foodstuffs, in general
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
A23L 5/30 - Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
72.
NOVEL GLNH PROTEIN MUTANT AND METHOD FOR PRODUCING L-GLUTAMIC ACID BY USING SAME
The present invention relates to a novel GlnH protein mutant and a method for producing L-glutamic acid by using same. In the GlnH protein mutant, one or more amino acids from among amino acid sequences constituting a GlnH protein are substituted to change protein activity, and thus L-glutamic acid can be efficiently produced from a recombinant microorganism comprising the mutant.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a novel ATP synthase variant and a method of producing an L-aromatic amino acid using the same. The ATP synthase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting ATP synthase to change the enzymatic activity of the ATP synthase, and a recombinant microorganism comprising the ATP synthase variant is capable of efficiently producing an L-aromatic amino acid.
The present invention relates to a microorganism that produces 1,4-butanediol and a method of producing 1,4-butanediol using same. The microorganism according to the present invention is able to efficiently produce 1,4-butanediol using ornithine as a carbon source, unlike naturally occurring microorganisms.
The present invention relates to a novel stress protein variant and a method of producing an L-aromatic amino acid using the same. The stress protein variant is obtained by substituting one or more amino acids in the amino acid sequence constituting glutathione reductase or stress protein B to change the activity of the protein, and a recombinant microorganism comprising the variant is capable of efficiently producing an L-aromatic amino acid.
Escherichia coli. Therefore, by using a recombinant strain transformed with an expression vector including the novel promoter variant according to the present disclosure, it is possible to economically mass-produce a target protein, particularly an enzyme. For example, by using a recombinant strain transformed with an expression vector including the novel promoter variant according to the present disclosure, it is possible to economically mass-produce allulose epimerase or economically mass-produce allulose from fructose.
The present invention relates to a microorganism of the genus Corynebacterium having enhanced L-arginine productivity and a method for producing L-arginine using same. The microorganism of the genus Corynebacterium has an improved L-arginine production yield, compared to the parent strain, by having, introduced thereinto, the argO gene encoding an arginine exporter, and thus can effectively produce L-arginine.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention provides a novel promoter variant in which some nucleotides of the glyceraldehyde-3-phosphate dehydrogenase (gapA) gene promoter of Escherichia coli are deleted. The novel promoter variant according to the present invention can constitutively express a target protein at a high level, particularly an enzyme, in Escherichia coli. Therefore, a target protein, particularly an enzyme, can be economically mass-produced using a recombinant strain transformed with an expression vector containing the novel promoter variant according to the present invention. For example, allulose epimerase can be economically mass-produced or allulose can be economically mass-produced from fructose using a recombinant strain transformed with an expression vector containing the novel promoter variant according to the present invention.
The present invention relates to a Corynebacterium glutamicum mutant strain having enhanced L-lysine productivity and a method of producing L-lysine using the same. The Corynebacterium glutamicum mutant strain is able to produce L-lysine in an improved yield as a result of improving the activity of glyceraldehyde 3-phosphate dehydrogenase by mutagenesis of amino acids in the gene encoding glyceraldehyde 3-phosphate dehydrogenase.
The present invention relates to a novel variant of the GNAT family N-acetyltransferase and a method for producing L-glutamic acid using same. In the variant of the GNAT family N-acetyltransferase, one or more amino acids in the amino acid sequence constituting the GNAT family N-acetyltransferase are substituted, resulting in a change in protein activity. Accordingly, L-glutamic acid can be efficiently produced from a recombinant microorganism expressing the variant.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
The present invention relates to a novel 2-methylcitrate dehydratase variant and a method for producing L-glutamic acid using same. The 2-methylcitrate dehydratase variant has changed protein activity due to the substitution of at least one amino acid in an amino acid sequence constituting a 2-methylcitrate dehydratase, and thus, L-glutamic acid can be efficiently produced from a recombinant microorganism expressing the variant.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
The present invention relates to a novel mutant of MtrAB system accessory protein LpqB and a method for producing L-glutamic acid using same. The mutant of MtrAB system accessory protein LpqB has changed protein activity obtained by substituting at least one amino acid among amino acid sequences constituting the MtrAB system accessory protein LpqB, and thus L-glutamic acid can be efficiently produced from a recombinant microorganism expressing the mutant.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
The present invention relates to a novel alkylhydroperoxidase AhpD family core domain variant, and a method for producing L-glutamic acid by using same. In the alkylhydroperoxidase AhpD family core domain variant, at least one amino acid from among amino acid sequences constituting the alkylhydroperoxidase AhpD family core domain is substituted such that protein activity is altered, and thus L-glutamic acid can be efficiently produced from a recombinant microorganism expressing the variant.
C12N 9/08 - Oxidoreductases (1.), e.g. luciferase acting on hydrogen peroxide as acceptor (1.11)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
The present invention relates to a novel 4-hydroxyphenyl-beta-ketoacyl-CoA hydrolase variant and a method for producing L-glutamic acid using same. Since the 4-hydroxyphenyl-beta-ketoacyl-CoA hydrolase variant has an altered protein activity due to substitution for at least one amino acid on the amino acid sequence constituting 4-hydroxyphenyl-beta-ketoacyl-CoA hydrolase, L-glutamic acid can be effectively produced from the recombinant microorganism expressing the variant.
C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 15/70 - Vectors or expression systems specially adapted for E. coli
The present invention relates to a genus Corynebacterium microorganism with improved L-glutamic acid productivity, and a method for producing L-glutamic acid by using same. The genus Corynebacterium microorganism has weakened or inactivated activity of polyphosphate kinase 2B, thereby having enhanced L-glutamic acid biosynthesis pathway, and thus can have better L-glutamic acid production yield than a parent strain.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
The present invention relates to a Corynebacterium sp. microorganism that produces L-glutamic acid and a method for producing L-glutamic acid using same and, specifically, to a myo-inositol facilitator IolT2 variant involved in the biosynthesis pathway of L-glutamic acid, a polynucleotide, and a transformant, as well as a method for producing L-glutamic acid using same. The myo-inositol facilitator IolT2 variant according to the present invention has altered protein activity due to the substitution of one or more amino acids in the amino acid sequence that constitutes IolT2, and a recombinant microorganism containing the variant can efficiently produce L-glutamic acid.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a corynebacterium sp. microorganism for producing L-glutamic acid, and a method for producing L-glutamic acid by using same, and, particularly, to: a variant, a polynucleotide and a transformant of transcriptional regulator IolR involved in the L-glutamic acid biosynthesis pathway; and a method for producing L-glutamic acid by using same. The transcriptional regulator IolR variant according to the present invention has one or more amino acids substituted in the amino acid sequence constituting the transcriptional regulator IolR, and thus the activity of the protein is altered such that a recombinant microorganism comprising the variant can efficiently produce L-glutamic acid.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
The present invention relates to a novel variant of PTS transporter subunit EIIC and a 5'-inosinic acid production method using same. The variant of PTS transporter subunit EIIC has, by the substitution of at least one amino acid in the amino acid sequence constituting a PTS transporter subunit EIIC, changed protein activity, and thus a recombinant microorganism including the variant of PTS transporter subunit EIIC can efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
89.
NOVEL VARIANT OF (P)PPGPP SYNTHETASE AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel variant of (p)ppGpp synthetase and a method for producing 5'-inosinic acid using same, the (p)ppGpp synthetase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting (p)ppGpp synthetase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
90.
NOVEL VARIANT OF PHOSPHOTRANSFERASE, AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel variant of phosphotransferase and a method for producing 5'-inosinic acid using same, the phosphotransferase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting phosphotransferase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
91.
NOVEL VARIANT OF PYRUVATE DEHYDROGENASE AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel variant of pyruvate dehydrogenase and a method for producing 5'-inosinic acid using same, the pyruvate dehydrogenase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting pyruvate dehydrogenase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
92.
NOVEL VARIANT OF ALDEHYDE DEHYDROGENASE AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel variant of aldehyde dehydrogenase and a method for producing 5'-inosinic acid using same, the aldehyde dehydrogenase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting aldehyde dehydrogenase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
93.
NOVEL FE-S CLUSTER ASSEMBLY PROTEIN SUFB VARIANT AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel Fe-S cluster assembly protein SufB variant and a method for producing 5'-inosinic acid using same. The Fe-S cluster assembly protein SufB variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting the Fe-S cluster assembly protein SufB, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
The present invention relates to a novel Fe-S cluster assembly protein SufD variant and a method for producing 5'-inosinic acid using same. The Fe-S cluster assembly protein SufD variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting the Fe-S cluster assembly protein SufD, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
The present invention relates to a novel Fe-S cluster assembly protein SufC variant and a method for producing 5'-inosinic acid using same. The Fe-S cluster assembly protein SufC variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting the Fe-S cluster assembly protein SufC, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
The present invention relates to a novel variant of nucleotide hydrolase and a method for producing 5'-inosinic acid using same, the nucleotide hydrolase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting nucleotide hydrolase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
97.
NOVEL 5-DEHYDRO-2-DEOXYGLUCONOKINASE VARIANT AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel 5-dehydro-2-deoxygluconokinase variant and a method for producing 5'-inosinic acid using same. The 5-dehydro-2-deoxygluconokinase variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting 5-dehydro-2-deoxygluconokinase, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
98.
NOVEL PHOSPHOENOLPYRUVATE CARBOXYLASE VARIANT AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel phosphoenolpyruvate carboxylase variant and a method for producing 5'-inosinic acid using same. The phosphoenolpyruvate carboxylase variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting phosphoenolpyruvate carboxylase, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
99.
NOVEL VARIANT OF THREONINE AMMONIA-LYASE AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel variant of threonine ammonia-lyase and a method for producing 5'-inosinic acid using same, the threonine ammonia-lyase variant having altered protein activity due to substitution of one or more amino acids in the amino acid sequence constituting threonine ammonia-lyase, thereby allowing recombinant microorganisms comprising the variant to efficiently produce 5'-inosinic acid.
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
100.
NOVEL ABC TRANSPORTER PERMEASE VARIANT AND METHOD FOR PRODUCING 5'-INOSINIC ACID USING SAME
The present invention relates to a novel ABC transporter permease variant and a method for producing 5'-inosinic acid using same. The ABC transporter permease variant has modified protein activity due to the substitution of one or more amino acids in the amino acid sequence constituting an ABC transporter permease, and thus recombinant microorganisms comprising same can efficiently produce 5'-inosinic acid.
C12P 19/32 - Nucleotides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
C12N 15/77 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium